Back

Frequency, causes and predictors for cancellation of elective electrical cardioversion of atrial fibrillation and flutter

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation cardioversion Rhythm Control, Cardioversion EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Victoria Svedung Wettervik

Uppsala University, Uppsala (Sweden)

6 More presentations in this session

Presentation thumbnail
Predictors of maintenance of sinus rhythm one year after successful cardioversion of persistent atrial fibrillation and atrial flutter
Assistant Professor N. Radovanovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of electrical cardioversion of atrial fibrillation in the emergency department (HEROMEDICUS study)
Doctor N. Argyriou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of spontaneous conversion to sinus rhythm in patients with symptomatic paroxysmal atrial fibrillation
Doctor P. Cipollone (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Naples score is related to failure to maintain sinus rhythm in long-standing persistent atrial fibrillation patients undergoing electrical cardioversion
Mr K. Gulsen (Turkey, TR)
Presentation thumbnail
Pharmacological cardioversion as a predictor of left atrial scarring in patients undergoing catheter ablation for persistent atrial fibrillation
Mr M. Keseru (Pecs, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation cardioversion

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Predictors of maintenance of sinus rhythm one year after successful cardioversion of persistent atrial fibrillation and atrial flutter
thumbnail
Congress Presentation
Left atrial thrombus in heart failure patients undergoing elective electrical cardioversion despite guideline-recommended anticoagulation: prevalence, predictors and prognosis
thumbnail
Congress Presentation
Pharmacological cardioversion as a predictor of left atrial scarring in patients undergoing catheter ablation for persistent atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources